PILA (PILA) News
Follow PILA (PILA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
PILA PHARMA AB (publ) (PILA) Starts Enrollment for 8-Patient Safety Cohort in 12-Week Obesity Trial
PILA PHARMA AB (publ) initiated and activated its first site and began enrollment for Part 1 (8 participants) of PP-CT04, a 12—week, randomized, placebo—controlled trial of XEN—D0501 in obesity. Part 2 may start after ≥5
NEWS | Sep 29, 2026, 11:01 AM UTC
L
Pila Pharma uploads recent H1 recordings and management interviews
Pila Pharma AB (publ) says recordings from recent activities and presentations, including management interviews, are now online.
EQUITY | Sep 08, 2026, 02:50 PM UTC
L
Pila Pharma advances higher doses in PP-CT04 study
Pila Pharma says it has taken the next step toward higher doses in its PP-CT04 study.
EQUITY | Sep 01, 2026, 07:46 AM UTC
L
PILA PHARMA reviews an eventful first half, with focus on upcoming obesity trials
PILA PHARMA reviews an eventful first half, with focus on upcoming obesity trials
EQUITY | Aug 28, 2026, 12:25 PM UTC
L
Research update Pila Pharma H1 2026: From rat detour to clinical heat
Research update Pila Pharma H1 2026: From rat detour to clinical heat
EQUITY | Aug 28, 2026, 05:37 AM UTC
L
Pila Pharma invites investors to H1 report Q&A on 27 August
Pila Pharma has invited investors to review its H1 report with Q&A on 27 August at 11:00 CET.
EQUITY | Aug 27, 2026, 07:10 AM UTC
L
Pila Pharma reports H1 operating loss of SEK 3.85 mln
Pila Pharma posted an H1 operating loss of SEK 3.85 mln.
EQUITY | Aug 27, 2026, 07:02 AM UTC
L
PILA regulatory approval and improved solvency cited in half-year results
TradingView News reports PILA regulatory approval for a key obesity trial and improved solvency highlighted in its half-year results.
EQUITY | Aug 27, 2026, 06:32 AM UTC
L
Pila Pharma publishes interim report for H1 2026
Pila Pharma has published its interim report covering 1 January to 30 June 2026.
EQUITY | Aug 27, 2026, 06:30 AM UTC